Pro Share Advisors LLC Gilead Sciences, Inc. Transaction History

Pro Share Advisors LLC

  • $42.9 Billion
  • Q1 2025

A detailed history of Pro Share Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 1,852,883 shares of GILD stock, worth $215 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,852,883
Previous 1,646,698 12.52%
Holding current value
$215 Million
Previous $152 Million 36.49%
% of portfolio
0.48%
Previous 0.36%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025
BUY
$89.14 - $117.41 $18.4 Million - $24.2 Million
206,185 Added 12.52%
1,852,883 $208 Million
Q4 2024

Feb 13, 2025
BUY
$83.95 - $97.9 $18.9 Million - $22 Million
224,825 Added 15.81%
1,646,698 $152 Million
Q3 2024

Nov 13, 2024
BUY
$66.59 - $83.99 $5.01 Million - $6.32 Million
75,206 Added 5.58%
1,421,873 $119 Million
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $8.48 Million - $9.79 Million
-134,320 Reduced 9.07%
1,346,667 $92.4 Million
Q1 2024

May 08, 2024
BUY
$71.58 - $87.29 $18.9 Million - $23 Million
263,645 Added 21.66%
1,480,987 $108 Million
Q4 2023

Feb 14, 2024
SELL
$73.27 - $83.09 $15.7 Million - $17.8 Million
-213,934 Reduced 14.95%
1,217,342 $98.6 Million
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $12.2 Million - $13.3 Million
165,000 Added 13.03%
1,431,276 $107 Million
Q2 2023

Aug 10, 2023
SELL
$76.01 - $86.7 $4.94 Million - $5.64 Million
-64,995 Reduced 4.88%
1,266,276 $97.6 Million
Q1 2023

May 11, 2023
BUY
$77.31 - $88.08 $8.61 Million - $9.81 Million
111,328 Added 9.13%
1,331,271 $110 Million
Q4 2022

Feb 02, 2023
SELL
$62.32 - $89.47 $10 Million - $14.4 Million
-160,923 Reduced 11.65%
1,219,943 $105 Million
Q3 2022

Nov 04, 2022
SELL
$59.54 - $68.01 $14.9 Million - $17.1 Million
-250,845 Reduced 15.37%
1,380,866 $85.2 Million
Q2 2022

Aug 01, 2022
SELL
$57.72 - $65.01 $46 Million - $51.8 Million
-796,722 Reduced 32.81%
1,631,711 $101 Million
Q1 2022

May 10, 2022
SELL
$57.92 - $72.58 $7.34 Million - $9.19 Million
-126,666 Reduced 4.96%
2,428,433 $144 Million
Q4 2021

Feb 08, 2022
BUY
$64.88 - $73.64 $49.9 Million - $56.6 Million
768,758 Added 43.04%
2,555,099 $186 Million
Q3 2021

Nov 12, 2021
BUY
$67.69 - $73.03 $11.5 Million - $12.4 Million
169,819 Added 10.51%
1,786,341 $125 Million
Q2 2021

Aug 13, 2021
SELL
$63.47 - $69.35 $1.27 Million - $1.39 Million
-20,008 Reduced 1.22%
1,616,522 $111 Million
Q1 2021

May 14, 2021
BUY
$60.0 - $68.46 $13.3 Million - $15.1 Million
220,876 Added 15.6%
1,636,530 $106 Million
Q4 2020

Feb 09, 2021
BUY
$56.65 - $64.55 $10.9 Million - $12.4 Million
191,724 Added 15.66%
1,415,654 $82.5 Million
Q3 2020

Nov 13, 2020
BUY
$62.1 - $78.08 $11.9 Million - $14.9 Million
191,280 Added 18.52%
1,223,930 $77.3 Million
Q2 2020

Aug 03, 2020
BUY
$72.34 - $84.0 $9.94 Million - $11.5 Million
137,440 Added 15.35%
1,032,650 $79.5 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $23.7 Million - $30.4 Million
-379,066 Reduced 29.75%
895,210 $66.9 Million
Q4 2019

Feb 12, 2020
BUY
$61.62 - $67.78 $6.98 Million - $7.68 Million
113,236 Added 9.75%
1,274,276 $82.8 Million
Q3 2019

Nov 12, 2019
BUY
$62.51 - $69.0 $1.32 Million - $1.46 Million
21,133 Added 1.85%
1,161,040 $73.6 Million
Q2 2019

Aug 13, 2019
SELL
$61.87 - $69.38 $10.2 Million - $11.4 Million
-164,587 Reduced 12.62%
1,139,907 $77 Million
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $2.14 Million - $2.4 Million
34,274 Added 2.7%
1,304,494 $84.8 Million
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $9.34 Million - $12.2 Million
154,322 Added 13.83%
1,270,220 $79.5 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $8.39 Million - $9.29 Million
-117,774 Reduced 9.55%
1,115,898 $86.2 Million
Q2 2018

Aug 13, 2018
SELL
$64.88 - $75.68 $5.31 Million - $6.19 Million
-81,803 Reduced 6.22%
1,233,672 $87.4 Million
Q1 2018

May 14, 2018
BUY
$72.84 - $88.8 $6.74 Million - $8.22 Million
92,535 Added 7.57%
1,315,475 $99.2 Million
Q4 2017

Feb 14, 2018
BUY
$71.15 - $83.52 $18.3 Million - $21.5 Million
256,850 Added 26.59%
1,222,940 $87.6 Million
Q3 2017

Nov 13, 2017
BUY
$72.11 - $85.47 $2.13 Million - $2.53 Million
29,577 Added 3.16%
966,090 $78.3 Million
Q2 2017

Aug 11, 2017
BUY
N/A
936,513
936,513 $66.3 Million

Others Institutions Holding GILD

# of Institutions
2,294
Shares Held
997M
Call Options Held
9.62M
Put Options Held
10M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $146B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email